Clinical trial
Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic…
NCT00313586 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00313586 |
|---|---|
| Title | Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia |
| Official title | A Randomized Phase II Trial of Azacitidine With or Without the Histone Deacetylase Inhibitor Entinostat for the Treatment of Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia (Dysplastic Type), and Acute Myeloid Leukemia With Multilineage Dysplasia |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22), CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16, 16)(p13.1, q22), Adult Acute Myeloid Leukemia With t(8, 21)(q22, RUNX1-RUNX1T1 and 16 more |
| Intervention type | Drug, Other |
| Interventions | Azacitidine, Entinostat, Laboratory Biomarker Analysis |
| Enrollment | 197 |
| Start date | Aug 1, 2006 |
| Primary completion | Jul 1, 2013 |
| Completion | Jul 1, 2013 |
| First posted | Apr 12, 2006 |
| Last update posted | Feb 2, 2017 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: